Teladoc Health
TDOC
7.45
-0.34
-4.36%
Teladoc Health
US · TDOC
#3241 by market cap
Listed 2015
7.45
-0.34
-4.36%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:44
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: BofA Securities moved from Hold to Buy on 2026-02-26.
Analyst consensus 12 analysts
Buy
Avg price target 9.44 +26.7%
Price target rangecurrent 7.45
Low7.00
Avg9.44
High10.50
Buy 33%
Hold 58%
Sell 8%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-04 | Barclays | -- | Hold | 9.00 |
| 2026-11-02 | Argus Research | -- | Sell | -- |
| 2026-11-02 | UBS | -- | Hold | 9.00 |
| 2026-11-02 | Oppenheimer | -- | Buy | 10.00 |
| 2026-10-30 | UBS | -- | Hold | 9.00 |
| 2026-10-30 | J.P. Morgan | -- | Hold | 10.00 |
| 2026-10-29 | Needham | -- | Hold | -- |
| 2026-10-28 | Cantor Fitzgerald | -- | Buy | 10.00 |
| 2026-10-28 | CCORF | -- | Buy | 10.00 |
| 2026-10-28 | BTIG | -- | Hold | -- |
| 2026-10-28 | BofA Securities | -- | Buy | 10.50 |
| 2026-10-28 | BMO Capital | -- | Hold | 7.00 |
| 2026-10-21 | Barclays | -- | Hold | 7.00 |
| 2026-09-24 | BofA Securities | -- | Buy | 10.50 |
| 2026-09-15 | BofA Securities | -- | Buy | 10.50 |
| 2026-09-01 | Truist Financial | -- | Hold | -- |
| 2026-08-31 | CCORF | -- | Buy | 10.00 |
| 2026-08-31 | BofA Securities | -- | Buy | 10.50 |
| 2026-08-14 | Truist Financial | -- | Hold | 8.00 |
| 2026-08-04 | Oppenheimer | -- | Buy | 7.00 |
| 2026-08-03 | Citi | -- | Hold | 7.50 |
| 2026-08-03 | Barclays | -- | Hold | 7.00 |
| 2026-07-30 | CCORF | -- | Buy | 10.00 |
| 2026-07-30 | BofA Securities | -- | Buy | 10.50 |
| 2026-07-30 | Truist Financial | -- | Hold | -- |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-02-26 | BofA Securities | Hold → Buy | 7.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-28 | After close | ±9.20% | +26.89% (beat) |
| 2026/Q2 | 2026-07-29 | After close | ±9.54% | -28.32% (beat) |
| 2026/Q1 | 2026-04-29 | After close | ±8.03% | +1.85% (in line) |
| 2025/Q4 | 2026-02-25 | After close | ±9.19% | +15.05% (beat) |
| 2025/Q3 | 2025-10-29 | After close | ±7.86% | +6.20% (in line) |
| 2025/Q2 | 2025-07-29 | After close | ±11.83% | -1.73% (in line) |
| 2025/Q1 | 2025-04-30 | After close | ±13.67% | -2.78% (in line) |
| 2024/Q4 | 2025-02-26 | After close | ±14.10% | -13.56% (in line) |
| 2024/Q3 | 2024-10-30 | After close | ±13.19% | +1.58% (in line) |
| 2024/Q2 | 2024-07-31 | After close | ±15.83% | -8.91% (in line) |
| 2024/Q1 | 2024-04-25 | After close | ±14.15% | -2.40% (in line) |
| 2023/Q4 | 2024-02-20 | After close | ±17.04% | -23.67% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:44:00 · For reference only, not investment advice and not tailored to your situation.
Teladoc Health discussion 0 comments